Avita Medical (ASX:AVH) signed an exclusive agreement with Revolution Surgical for the distribution of the Recell product platform for thermal burn wound treatment, according to a Wednesday filing with the Australian bourse.
Revolution Surgical will be the exclusive distributor of Recell products in Australia and New Zealand under the deal, the filing said.
Avita Medical shares rose nearly 4% in midday trade Wednesday.
Price (AUD): $3.81, Change: $+0.13, Percent Change: +3.53%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments